Rein Therapeutics stockholders approve increase in authorized shares to 200M, re-elect directors

Rein Therapeutics, Inc.

Elected Josef H. von Rickenbach and Reinhard J. Ambros as Class III directors.
Approved amendment to increase authorized common shares from 100M to 200M (61.0M for, 2.4M against).
Ratified CBIZ CPAs P.C. as independent auditor for FY2026 (62.95M for, 0.17M against).
Advisory say-on-pay approved with 37.6M for, 0.9M against, 25.1M broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.